Andrew I. Koven, President & Chief Business Officer at Aralez Pharmaceuticals Inc. (ARLZ), bought 143,000 shares at $3.49 ($499K) on 2016-05-12, disclosed to the SEC on 2016-05-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.49 | 71,500 | $250K | 50.0% |
| 2 | $3.49 | 71,500 | $250K | 50.0% |
| Total | $3.49 avg | 143,000 | $499K | 100% |
| Filing → |
| ARLZ | SELL | 2018-03-21 | $17K | — | Filing → |
| ARLZ | SELL | 2017-06-06 | $414K | — | Filing → |
| ARLZ | SELL | 2017-03-22 | $19K | — | Filing → |